Epilepsy, a chronic neurological disorder, is characterized by recurrent seizures. The last decade has seen significant advancements in its management. This article aims to provide a comprehensive update on these developments for healthcare professionals.
The past decade has witnessed the introduction of several new AEDs. These drugs, including Brivaracetam, Perampanel, and Lacosamide, have shown improved seizure control and fewer side effects compared to older drugs. They offer new mechanisms of action and are often effective in patients who are resistant to traditional AEDs.
Neuromodulation devices, such as Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS), have proven effective in reducing seizure frequency. They provide an alternative treatment option for patients who are not candidates for epilepsy surgery or those who have not responded to AEDs.
Advancements in neuroimaging and surgical techniques have improved the outcomes of epilepsy surgery. Minimally invasive procedures, such as Laser Interstitial Thermal Therapy (LITT), allow for precise ablation of epileptogenic zones with reduced morbidity. Furthermore, stereotactic EEG enables accurate localization of seizure foci, increasing the success rate of surgical interventions.
Genetic testing has emerged as a critical tool in the management of epilepsy. It allows for the identification of specific genetic mutations associated with epilepsy syndromes, facilitating personalized treatment plans. Moreover, it can provide valuable information for genetic counseling.
The advancements in epilepsy management have revolutionized the approach to this complex neurological disorder. The introduction of new AEDs, neuromodulation devices, improved surgical techniques, and genetic testing have significantly improved patient outcomes. It is essential for healthcare professionals to stay updated with these advancements to provide optimal care for patients with epilepsy.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation